- Home
- NEO vs BCRX Comparison
NEO vs BCRX Comparison
Compare NEO & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | BCRX |
|---|---|---|
| Founded | 2001 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.1B |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NEO | BCRX |
|---|---|---|
| Price | $7.90 | $8.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $11.14 | ★ $20.82 |
| AVG Volume (30 Days) | 2.0M | ★ 4.1M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $9.73 | $12.55 |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.72 | $6.00 |
| 52 Week High | $13.74 | $11.31 |
Technical Indicators
Market Signals| Indicator | NEO | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 19.28 | 57.26 |
| Support Level | $7.07 | $7.95 |
| Resistance Level | $8.89 | $8.68 |
| Average True Range (ATR) | 0.47 | 0.33 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 2.30 | 51.57 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.